Zota Health Care Limited

ZOTA

INE358U01012

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 02:41:21 16/05/2024 pm IST			5-day change	1st Jan Change
478.6 ^INR	-0.21%		+1.32%	+1.30%

08/03	Zota Health Care Limited Announces Resignation of Manukant Chandulal Zota as Whole-Time Director, Effective March 31, 2024	CI
08/02	Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Zota Health Care Limited Receives Product Registration Licenses for Ten Products from Turkmenistan

September 14, 2021 at 04:46 pm IST

Zota Health Care Limited have received product registration licenses for below mentioned ten products from Turkmenistan. 1; ZOFEN-L00 (Tablet- Each tablet contains Aceclofenac 1O0mg) NSAID, 2; ZOTALAN 30 (Capsule - Each tablet contains Lansoprazole PPI 30mC) 3;,AIRONA-20 (Tablet- Each tablet contains Atorvastatin 2OmB) Antihyperljpidemic, 4; ATRONA-40 (Tablet- Each tablet contains Atorvastatin 4omg) Anti hyperlipidemic, 5; CLARIZED 500 (Tablet - Each tablet contains Clarlthromyctn Antibiotics 500mg), 6; LORGIC 10 (Tablet- Each tablet contains Loratadine lomg) Antihistamini. 7; S-AMtOZED 2.5 (Tab - Each Tablet contains S-Amlodipine Calcium Channel Blocker 2.5ms), 8; s-AMLOZED 5 (Tab - Each Tablet contains S-Amlodipine smg) Calcium Channel Blocker, 9; Z-OFLOX 200 (Tablet - Each tablet contains Ofloxacin 2OOmB) Antibiotics, 10;ZOCOLIN 500 (Tablet - Each tablet contains Citicoline 50OmB) Psychostimulants.

Latest news about Zota Health Care Limited

Zota Health Care Limited Announces Resignation of Manukant Chandulal Zota as Whole-Time Director, Effective March 31, 2024	08/03	CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02	CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Zota Health Care Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/23/30	CI
Zota Health Care Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/23/30	CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13	CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/22/13	CI
Zota Health Care Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/22/30	CI
Zota Health Care Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/22/30	CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	12/22/12	CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	01/21/01	CI
Zota Health Care Limited Recommends Final Dividend for the Financial Year 2020-21	14/21/14	CI
Zota Health Care Limited Receives Product Registration Licenses for Ten Products from Turkmenistan	14/21/14	CI
Zota Health Care Limited Proposes Declaration of Final Dividend for the Financial Year 2020-21	02/21/02	CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	30/21/30	CI
Zota Health Care Limited Receives Product Licenses from Ministry of Health, Cambodia	05/21/05	CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	10/21/10	CI
Zota Health Care Limited Receives Renewal of License to Work a Factory	12/20/12	CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	11/20/11	CI
Zota Health Care Limited Announces Launching of New Store Segment 'DAVAINDIA AYURVEDA & WELLNESS' Under Brand DAVAINDIA	04/20/04	CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	25/20/25	CI
Zota Health Care Limited Recommends Final Dividend for the Financial Year 2019-20	23/20/23	CI
3,545,712 Equity Shares of Zota Health Care Limited are subject to a Lock-Up Agreement Ending on 11-MAY-2020.	11/20/11	CI
Zota Health Care Limited Launches New Product with the Name "COROWL" for Viral Lnfection	28/20/28	CI

Chart Zota Health Care Limited

Duration

Period

More charts

Company Profile

Zota Health Care Limited is an India-based drug development, manufacturing and marketing company. The Company manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Companyâs business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain (Davaindia). Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Companyâs distribution network across India. It has a portfolio of more than 3,000 products in various categories, such as generics, OTC products, allopathic, ayurvedic and others. In the Retail Pharmacy Chain business vertical, it operates a chain of pharmacy stores under the brand Davaindia. Its domestic products include AMLOTOZ AT Tab, APIXACEED 2.5 Tab, APIXACEED 5 Tab, ATRONA 10 Tab, ATRONA 20 Tab, ATRONA 40 Tab, ATRONA ASP 75 Cap, ATRONA ASP 150 Cap, ATRONA ASP 20/75 Cap, ATRONA FB Tab and others.

Sector

Pharmaceuticals

Calendar

21/06/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZOTA HEALTH CARE LIMITED	+1.30%	145M
ELI LILLY AND COMPANY	+35.01%	709B
NOVO NORDISK A/S	+30.64%	595B
JOHNSON & JOHNSON	-2.60%	367B
MERCK & CO., INC.	+20.83%	334B
ABBVIE INC.	+5.69%	289B
ASTRAZENECA PLC	+14.09%	239B
NOVARTIS AG	+9.33%	211B
ROCHE HOLDING AG	-3.31%	203B
AMGEN INC.	+10.77%	171B

Other Pharmaceuticals